Evidence map›Paper›PMID 40737218›Full record

Trial reportEuropean heart journal2025

Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction.

Masatake Kobayashi, Antoni Bayes-Genis, Kevin Duarte, John J V McMurray, João Pedro Ferreira, Stuart J Pocock, Dirk J Van Veldhuisen, Josep Lupón, Bertram Pitt, Faiez Zannad and 1 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European heart journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masatake KobayashiUniversité de Lorraine, and the CardioRenal Integration Clinical Investigation Center, INSERM, CHU de Nancy, Rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.ORCID 0000-0003-0008-2256
Antoni Bayes-GenisHeart Institute, University Hospital Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-3044-197X
Kevin DuarteUniversité de Lorraine, and the CardioRenal Integration Clinical Investigation Center, INSERM, CHU de Nancy, Rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.
John J V McMurrayBHF Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
João Pedro FerreiraUniversité de Lorraine, and the CardioRenal Integration Clinical Investigation Center, INSERM, CHU de Nancy, Rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.
Stuart J PocockDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-2212-4007
Dirk J Van VeldhuisenDepartment of Cardiology, University of Groningen, Groningen, The Netherlands.
Josep LupónHeart Institute, University Hospital Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-5601-9611
Bertram PittDepartment of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.ORCID 0000-0001-5880-275X
Faiez ZannadUniversité de Lorraine, and the CardioRenal Integration Clinical Investigation Center, INSERM, CHU de Nancy, Rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.
Nicolas GirerdUniversité de Lorraine, and the CardioRenal Integration Clinical Investigation Center, INSERM, CHU de Nancy, Rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.ORCID 0000-0002-3278-2057

Funding

the Contrat de Plan Etat Région Lorraine and FEDER IT2MPthe French National Research Agency Fighting Heart Failure ANR-15-RHU-0004the French PIA project Lorraine Université d'Excellence GEENAGE ANR-15-IDEX-04-LUE
6 · The paper itself

Abstract

BACKGROUND AND

aimsWorsening kidney function is a key prognostic factor in heart failure (HF) with reduced ejection fraction (HFrEF). However, associations between kidney function trajectories and HF-related events remain unclear.

methodsLongitudinal changes in estimated glomerular filtration rate (eGFR) before and after a HF-related event, defined as HF hospitalization or HF death, were examined using individual patient data from two clinical trials (EPHESUS and EMPHASIS-HF) and a real-world cohort (BARCELONA).

resultsHF-related events occurred in 14.1% of 8587 patients [EPHESUS/EMPHASIS-HF; median follow-up 17.1 (12.4-22.7) months] and 33.8% of 2048 patients [BARCELONA; median 47.0 (18.8-90.6) months]. In EPHESUS and EMPHASIS-HF, patients who experienced an HF-related event had a steeper decline in eGFR in the year preceding the event (average -4.83 mL/min/1.73 m²/year) compared with those who did not have an HF-related event (-1.18 mL/min/1.73 m²/year). Over the 1 year following an HF-related event, eGFR continued to decline, though at a slower rate (average -3.45 mL/min/1.73 m²/year). Similar kidney function trajectories were observed in BARCELONA (average eGFR decline -1.35 mL/min/1.73 m²/year in patients without HF event vs -5.77 mL/min/1.73 m²/year 1 year before an event and -3.04 mL/min/1.73 m²/year over the year after an event). Worsening New York Heart Association class paralleled steeper eGFR decline prior to HF events.

conclusionsIn HFrEF, kidney function decline may precede a HF hospitalization or death by up to 1 year, linking to symptomatic congestion. Monitoring eGFR slopes rather than relying solely on specific cut-off values may allow early detection of at-risk patients.

Indexed as

Heart FailureAgedFemaleGlomerular Filtration RateHospitalizationHumansMaleMiddle AgedPrognosisStroke VolumeCardiorenal syndromeHeart failure hospitalizationheart failure with reduced ejection fractionKidney functionMineralocorticoid receptor antagonist

Identifiers

PMID40737218
PMCPMC12614968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.